0 to <3 Years | ≥3 to <6 Years | ≥6 Years | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cancer incidence (ICD-O-3 site and histology codes) | Observed | Expected | Person-years | SIR (95% CI) | Observed | Expected | Person-years | SIR (95% CI) | Observed | Expected | Person-years | SIR (95% CI) |
All malignant neoplasms (C000–C970) excluding skin cancer (C440–449) | 499 | 286.29 | 21 505 | 1.74 (1.59 to 1.90) | 200 | 177.58 | 12 240 | 1.13 (0.98 to 1.29) | 220 | 194.66 | 11 898 | 1.13 (0.99 to 1.29) |
All malignant neoplasms (C000–C970) excluding skin cancer (C440–C449) and oesophageal cancer (C150–159) | 434 | 285.03 | 21 593 | 1.52 (1.38 to 1.67) | 177 | 177.47 | 12 336 | 1.00 (0.86 to 1.16) | 194 | 194.78 | 12 036 | 1.00 (0.86 to 1.15) |
Malignant neoplasms of digestive organs (C150–C260) | 203 | 55.39 | 21 879 | 3.67 (3.18 to 4.21) | 73 | 35.95 | 12 779 | 2.03 (1.59 to 2.55) | 69 | 42.79 | 12 963 | 1.61 (1.25 to 2.04) |
Malignant neoplasms of digestive organs excluding oesophagus (C160–C260) | 134 | 52.57 | 21 971 | 2.55 (2.14 to 3.02) | 43 | 34.20 | 12 885 | 1.26 (0.91 to 1.69) | 41 | 40.67 | 13 116 | 1.01 (0.72 to 1.37) |
Malignant neoplasms of the oesophagus (C150–C159) | 70 | 3.21 | 22 047 | 21.81 (17.00 to 27.55) | 31 | 2.20 | 12 931 | 14.11 (9.58 to 20.02) | 32 | 2.73 | 13 135 | 11.72 (8.02 to 16.55) |
Malignant neoplasms of the stomach (C160–C169) | 36 | 5.39 | 22 089 | 6.68 (4.68 to 9.25) | 9 | 3.53 | 12 997 | 2.55 (1.17 to 4.84) | 12 | 4.17 | 13 255 | 2.88 (1.49 to 5.03) |
Malignant neoplasms of the oesophagus (C150–C159) and stomach (C160–C169) | 105 | 8.55 | 21 996 | 12.29 (10.05 to 14.87) | 40 | 5.66 | 12 890 | 7.07 (5.05 to 9.62) | 43 | 6.82 | 13 090 | 6.31 (4.56 to 8.50) |
Malignant neoplasms of the cardia (C160) | 27 | 1.77 | 22 100 | 15.29 (10.07 to 22.24) | 7 | 1.16 | 13 006 | 6.03 (2.43 to 12.43) | 11 | 1.37 | 13 266 | 8.04 (4.01 to 14.38) |
Malignant neoplasms of the oesophagus (C150–C159) or cardia (C160) | 96 | 4.95 | 22 007 | 19.39 (15.71 to 23.68) | 38 | 3.33 | 12 899 | 11.41 (8.07 to 15.66) | 43 | 4.06 | 13 101 | 10.58 (7.66 to 14.25) |
Oesophageal adenocarcinoma (C150–C159 and 8140–8575) | 62 | 1.96 | 22 060 | 31.66 (24.27 to 40.59) | 30 | 1.37 | 12 939 | 21.94 (14.80 to 31.32) | 29 | 1.75 | 13 137 | 16.62 (11.13 to 23.86) |
Malignant neoplasms of the colon, rectosigmoid junction and anus (C180–C219) | 55 | 31.94 | 22 055 | 1.72 (1.30 to 2.24) | 15 | 20.55 | 12 958 | 0.73 (0.41 to 1.20) | 16 | 23.95 | 13 187 | 0.67 (0.38 to 1.08) |
Malignant neoplasms of the trachea, bronchus and lung (C330–C349) | 51 | 35.13 | 22 095 | 1.45 (1.08 to 1.91) | 23 | 23.23 | 12 994 | 0.99 (0.63 to 1.49) | 27 | 27.56 | 13 237 | 0.98 (0.65 to 1.43) |
Malignant neoplasms of the prostate (C619) | 81 | 72.44 | 14 449 | 1.12 (0.89 to 1.39) | 41 | 45.08 | 8488 | 0.91 (0.65 to 1.23) | 58 | 50.16 | 9014 | 1.16 (0.88 to 1.49) |
*Barrett’s oesophagus defined as ICD-9 code 530.85, or 530.2 with SNOMED M73330.
EAR, excess absolute risk; ICD-O, International Classification of Diseases for Oncology; SIR, standardised incidence ratio; SNOMED, Systematised Nomenclature of Medicine.